| Synonyms | KLK-9, Kallikrein-like protein 3, KLK-L3, FocusOn006 |
| Swiss Prot Num | Q9UKQ9 |
| Immunogen | This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human KLK9. |
| Product Type | Antibodies |
| Storage | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch. |
| References | 1. Yousef, G.M., et al., Genomics 65(2):184-194 (2000). 2. Diamandis, E.P., et al., Trends Endocrinol. Metab. 11(2):54-60 (2000). 3. Yousef, G.M., et al., Anticancer Res. 19 (4B), 2843-2852 (1999). 4. Yousef, G.M., et al., Anticancer Res. 79, 2843-2852 (1999). |
|
| Format | State: Liquid purified Ig |
| ? | Purification: Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS |
| ? | Buffer System: PBS with 0.09% (W/V) sodium azide |
|
| Specificity | This antibody reacts to Kallikrein 9 (KLK9). |
| Application | ELISA: 1/1,000. Western blotting: 1/100 - 1/500. |
| Background | Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK9 is a novel kallikrein with poptential application for diagnosis, monitoring and therapeutics of various cancers including those of the breast, prostate and testis. |
| Caution | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Concentration | 0.25 mg/ml |
| Focuson | 006 Antibodies to Kallikrein Family |
